Sunitinib in Treating Patients With Kidney Cancer That Has Spread to the Brain
NCT00814021
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
21
Enrollment
OTHER
Sponsor class
Conditions
Kidney Cancer
Metastatic Cancer
Interventions
DRUG:
sunitinib malate
Sponsor
Institut Claudius Regaud